HER-3 peptide vaccine (Ohio State University)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHER-3 peptide vaccine (Ohio State University)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Application > Therapeutic vaccineBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionReceptor tyrosine-protein kinase erbB-3 modulators
TargetsReceptor tyrosine-protein kinase erbB-3
Therapy Area/IndicationsOvarian NeoplasmsPancreatic NeoplasmsColonic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Ohio State University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesThe Ohio State UniversityImugene Ltd
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsPancreatic NeoplasmsColonic Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A